Bruce Roth

Bruce Roth is a Senior Scientist II at Inzen Therapeutics, with responsibilities in the In Vitro Disease Modeling Group, focusing on immune-oncology and neurobiology project teams. Prior to this, Bruce worked at Alkermes as a Senior Scientist and Associate Principal Scientist, contributing to gene expression and functional genomic analysis. Bruce's previous experience includes roles as an Institute Research Investigator at MD Anderson Cancer Center, focusing on neurodegeneration targets for Alzheimer's disease, and as a Sr. Research Scientist at Vertex Pharmaceuticals, where Bruce developed high-throughput imaging assays. Bruce began a career in research and development at Myrexis, Inc., and has held various positions across notable companies, culminating in extensive expertise in drug discovery and neurobiology. Bruce holds a BS in Microbiology from Oregon State University, obtained between 1984 and 1987.